These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10444430)

  • 1. A new model of cancer cachexia: contribution of the ubiquitin-proteasome pathway.
    Lazarus DD; Destree AT; Mazzola LM; McCormack TA; Dick LR; Xu B; Huang JQ; Pierce JW; Read MA; Coggins MB; Solomon V; Goldberg AL; Brand SJ; Elliott PJ
    Am J Physiol; 1999 Aug; 277(2):E332-41. PubMed ID: 10444430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.
    Attaix D; Combaret L; Tilignac T; Taillandier D
    Mol Biol Rep; 1999 Apr; 26(1-2):77-82. PubMed ID: 10363651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The balance between glucocorticoids and insulin regulates muscle proteolysis via the ubiquitin-proteasome pathway.
    Bailey JL; Wang X; Price SR
    Miner Electrolyte Metab; 1999; 25(4-6):220-3. PubMed ID: 10681643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats.
    Lecker SH; Solomon V; Price SR; Kwon YT; Mitch WE; Goldberg AL
    J Clin Invest; 1999 Nov; 104(10):1411-20. PubMed ID: 10562303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats.
    Combaret L; Rallière C; Taillandier D; Tanaka K; Attaix D
    Mol Biol Rep; 1999 Apr; 26(1-2):95-101. PubMed ID: 10363654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedicine. Protein loss in cancer cachexia.
    Tisdale MJ
    Science; 2000 Sep; 289(5488):2293-4. PubMed ID: 11041796
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
    Tilignac T; Temparis S; Combaret L; Taillandier D; Pouch MN; Cervek M; Cardenas DM; Le Bricon T; Debiton E; Samuels SE; Madelmont JC; Attaix D
    Cancer Res; 2002 May; 62(10):2771-7. PubMed ID: 12019153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight gain does not preclude increased ubiquitin conjugation in skeletal muscle: an exploratory study in tumor-bearing mice.
    Jatoi A; Cleary MP; Tee CM; Nguyen PL
    Ann Nutr Metab; 2001; 45(3):116-20. PubMed ID: 11423703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.
    Whitehouse AS; Tisdale MJ
    Biochem Biophys Res Commun; 2001 Jul; 285(3):598-602. PubMed ID: 11453634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma.
    Baracos VE; DeVivo C; Hoyle DH; Goldberg AL
    Am J Physiol; 1995 May; 268(5 Pt 1):E996-1006. PubMed ID: 7539218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia.
    Khal J; Wyke SM; Russell ST; Hine AV; Tisdale MJ
    Br J Cancer; 2005 Oct; 93(7):774-80. PubMed ID: 16160695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-proteasome-dependent proteolysis in skeletal muscle.
    Attaix D; Aurousseau E; Combaret L; Kee A; Larbaud D; Rallière C; Souweine B; Taillandier D; Tilignac T
    Reprod Nutr Dev; 1998; 38(2):153-65. PubMed ID: 9638789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia.
    Chai J; Wu Y; Sheng ZZ
    Crit Care Med; 2003 Jun; 31(6):1802-7. PubMed ID: 12794423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
    Jagoe RT; Goldberg AL
    Curr Opin Clin Nutr Metab Care; 2001 May; 4(3):183-90. PubMed ID: 11517350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting.
    Mitch WE; Bailey JL; Wang X; Jurkovitz C; Newby D; Price SR
    Am J Physiol; 1999 May; 276(5):C1132-8. PubMed ID: 10329962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway.
    Mitch WE; Goldberg AL
    N Engl J Med; 1996 Dec; 335(25):1897-905. PubMed ID: 8948566
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
    Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
    Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cachexia in cancer patients.
    Tisdale MJ
    Nat Rev Cancer; 2002 Nov; 2(11):862-71. PubMed ID: 12415256
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.
    Acharyya S; Ladner KJ; Nelsen LL; Damrauer J; Reiser PJ; Swoap S; Guttridge DC
    J Clin Invest; 2004 Aug; 114(3):370-8. PubMed ID: 15286803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.